Immunology and Microbiology
Alveolar Macrophage
13%
Bacterial Clearance
10%
Bioenergy
7%
Bioluminescence
11%
Blood Brain Barrier
7%
Blood Plasma
6%
Bone Marrow-Derived Macrophage
22%
Complement Factor B
7%
COVID-19
10%
Epigenetics
6%
Exosome
12%
Gene Expression
24%
Host Factor
7%
Host Resistance
26%
Host-Pathogen Interaction
7%
Human Immunodeficiency Virus
10%
Human Immunodeficiency Virus 1
17%
Immune Response
17%
Immunomodulation
5%
Immunosuppressive Drug
10%
Infectious Agent
12%
Inflammation Response
14%
Innate Immune System
14%
Leukocyte
9%
Liver Transplantation
5%
Lower Respiratory Tract
6%
Macrophage
100%
Macrophage Response
5%
Mediator
11%
Monocyte
7%
Mouse
55%
Myeloid
42%
Neutrophil
9%
Neutrophil Granulocyte
14%
Nontuberculous mycobacteria
25%
Peroxisome
13%
Peroxisome Proliferator Activated Receptor Gamma Coactivator 1alpha
5%
Prostaglandin
15%
Prostaglandin E2
12%
Pseudomonas aeruginosa
62%
Pulmonary Inflammation
27%
Rothia mucilaginosa
5%
Sarcoidosis
6%
Signal Transduction
7%
TLR4
12%
Transcription Factor Nrf2
12%
Transgenics
5%
Unfolded Protein Response
8%
Wild Type
6%
Wiskott-Aldrich Syndrome
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lung Injury
24%
Adult Respiratory Distress Syndrome
33%
Alisma orientale
10%
Alternative Complement Pathway C3 C5 Convertase
22%
Bacterial Infection
12%
Biological Marker
9%
Chronic Obstructive Lung Disease
16%
Curcumin
8%
Cyclooxygenase 2
10%
Cystic Fibrosis
8%
Cytokine
8%
Disease
37%
Disease Severity
6%
Dyspnea
9%
Endotoxin
11%
Experimental Animal
6%
Host Factor
8%
Hypoxemia
7%
Immunosuppressive Agent
9%
Infection
28%
Infectious Agent
10%
Inflammation
30%
Injury
26%
Interstitial Lung Disease
10%
Lipopolysaccharide
23%
Lipopolysaccharide-Induced Acute Lung Injury
10%
Luciferase
20%
Lung Cancer
7%
Lung Disease
15%
Lung Infection
6%
Metastasis
17%
Mouse
51%
Mouse Model
15%
Nuclear Factor
23%
Peroxisome Proliferator Activated Receptor
8%
Phosphotransferase
11%
Placebo
10%
Pneumonia
40%
Pseudomonas aeruginosa
47%
Pseudomonas Pneumonia
13%
Reactive Oxygen Metabolite
8%
Recurrent Disease
10%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase
7%
Respiratory Tract Inflammation
6%
Sarcoidosis
6%
Sepsis
6%
Therapeutic Effect
7%
Transcription Factor Nrf2
14%
Triggering Receptor Expressed on Myeloid Cells 1
7%
Tumor Growth
6%
Keyphrases
Acute Lung Injury
7%
Acute Respiratory Distress Syndrome
10%
Airway Epithelium
16%
Aralia Continentalis
5%
Bacterial Infection
13%
Bacterial Pathogens
8%
Bioluminescence Imaging
10%
Bone Marrow-derived Macrophages
7%
Bronchiectasis
10%
Chronic Obstructive Pulmonary Disease
9%
Cyclooxygenase-2
15%
Gene Expression
18%
Host Defense
22%
Host Response
6%
Induced Expression
5%
Inflammation
7%
Inflammatory Lung Disease
8%
Inflammatory Response
7%
Innate Immunity
5%
Lipopolysaccharide
14%
Lipopolysaccharide-induced
6%
Luciferase
6%
Lung
17%
Lung Inflammation
11%
Macrophages
29%
Myeloid Differentiation Factor 88 (MyD88)
10%
Neutrophilic Inflammation
7%
NF-B
26%
Non-small Cell Lung Cancer (NSCLC)
10%
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
10%
Nuclear factor-B
10%
P. Aeruginosa Infection
8%
P47phox
10%
Patient Characteristics
7%
Phospholipid Micelles
6%
Phosphorylation
5%
Placebo
7%
Pneumonia
13%
Prostaglandin D2 (PGD2)
9%
Prostaglandins
5%
Pseudomonas
7%
Pseudomonas Aeruginosa (P. aeruginosa)
21%
Pseudomonas Aeruginosa Infection
5%
PU.1
17%
Reactive Oxygen Species
5%
Sarcoidosis
6%
TLR Ligands
5%
Transcription Factor
6%
TREM-1
31%
Tuberculosis Relapse
10%
